Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
- PMID: 39841973
- PMCID: PMC12005043
- DOI: 10.1164/rccm.202406-1143RL
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Update of
-
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.medRxiv [Preprint]. 2024 May 17:2024.05.16.24307300. doi: 10.1101/2024.05.16.24307300. medRxiv. 2024. Update in: Am J Respir Crit Care Med. 2025 Apr;211(4):650-654. doi: 10.1164/rccm.202406-1143RL. PMID: 38798603 Free PMC article. Updated. Preprint.
References
-
- Brantly M, Avila NA, Shotelersuk V, Lucero C, Huizing M, Gahl WA. Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest . 2000;117:129–136. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
